The outcome of hip replacement surgery and the survival of implants have improved during the last decades ([@CIT0015], [@CIT0023], [@CIT0007]). However, an increase in the risk of revision due to infection after THA has also been reported in recent years ([@CIT0021], [@CIT0001], [@CIT0035]). We wanted to assess whether the increase in risk of revision due to infection is a common feature in the Nordic countries, and we therefore assessed time trends and risk factors for revision due to infection after primary total hip arthroplasty (THA) in the Nordic countries (Denmark, Finland, Norway, and Sweden). The aim was to compare revision rates due to infection in different time periods and different patient and implant groups, and to investigate factors that influence the risk of revision due to infection.

Materials and methods {#ss1}
=====================

The Nordic Arthroplasty Register Association dataset {#ss2}
----------------------------------------------------

The NARA dataset contains merged individual-based data from the Danish, Finnish, Norwegian, and Swedish arthroplasty registers ([@CIT0016], [@CIT0010], [@CIT0024], [@CIT0037], [@CIT0026], [@CIT0011]). In each register, the data selected were transformed according to a common set of definitions, and revisions were linked to the primary procedures. The data were de-identified nationally before the anonymous data were merged into the NARA dataset. The data were treated in full confidentiality and in compliance with the regulations of each country ([@CIT0011]).

The inclusion criteria in the present study were primary THAs and first revisions from the period 1995 through 2009, with complete information on the following parameters: year of primary surgery and first revision, age, sex, diagnosis (osteoarthrosis (OA), inflammatory hip disease, hip fracture, childhood hip disease, femoral head necrosis, or other diagnoses), prosthesis (monoblock or modular), and type of fixation (uncemented, cemented, hybrid, or inverse hybrid, with plain or antibiotic-loaded cement). Primary THA was defined as the first total hip prosthesis regardless of cause of the arthroplasty. The endpoint was revision due to infection, and revision was defined as removal or exchange of the whole or part(s) of the prosthesis. Infection as the cause of revision was determined and reported by the surgeon immediately after surgery, based on the preoperative clinical manifestations and samples in addition to peroperative evaluation. The national datasets were harmonized according to these definitions. Of the 459,540 primary arthroplasties in the NARA dataset, 7,450 resurfacing arthroplasties were not considered as THAs. Of the 452,090 THAs, 3,397 were excluded due to unknown type of fixation, as were 16,525 THAs due to incomplete information on the risk factors. 432,168 THAs met the inclusion criteria. Denmark contributed 83,853 primary THAs, Finland 78,106, Norway 88,455, and Sweden 181,754 ([Table 1](#T1){ref-type="table"}).

###### 

Patient and procedure characteristics for the primary THAs included, and number of primary THAs excluded over the 3 time periods

                            1995-1999   2000-2004   2005-2009   1995-2009
  ------------------------- ----------- ----------- ----------- --------------
  Number of THAs included   113,280     147,823     171,065     432,168
  Age (%)                                                       
   \<40 years               2           1           1           1
   40--59 years             17          18          17          17
   60--69 years             29          29          32          30
   70--79 years             38          37          35          36
   80--89 years             14          15          15          15
   ≥90 years                1           1           1           1
  Sex (%) Female            63          62          61          61
  Diagnosis (%)                                                 
   Osteoarthritis           76          80          83          80
   Hip fracture             10          7           6           8
   Inflammatory disease     5           4           2           4
   Childhood hip disease    4           4           3           3
   Femoral head necrosis    2           2           2           2
   Other diagnoses          2           3           3           3
  Prosthesis (%)                                                
   Monoblock                22          10          2           10
   Modular                  78          90          98          90
  Fixation (%)                                                  
   Uncemented               13          16          30          21
   Cemented                 76          71          56          67
   Hybrid                   10          10          6           9
   Inverse hybrid           1           3           8           4
  Cement (%)                                                    
   No????                   13          16          30          21
   With antibiotics         71          79          69          73
   Without antibiotics      15          5           1           6
  Country (%)                                                   
   Denmark                  14          20          22          21
   Norway                   23          21          19          20
   Sweden                   45          42          41          42
   Finland                  19          17          18          18
  Number of THAs excluded   10,540      3,303       6,169       9,922 (4.4%)

Statistics {#ss3}
----------

Descriptive statistics were used for presentation of the patient and procedure characteristics. Adjusted Cox regression analyses were performed to assess relative risk of revision due to infection and to estimate adjusted cumulative 5-year probability (risk) of revision. Unadjusted cumulative 5-year risks of revision due to infection were estimated by the Kaplan-Meier (KM) method. The study population was divided into 5-year periods (1995--1999, 2000--2004, and 2005--2009). The cases were observed until first revision, death, emigration, or December 31, 2010. We also investigated changes in the revision rates due to deep infection as a function of the year of operation, to give a graphical display of the relationship based on a generalized additive model for survival data ([@CIT0009]). Adjusted hazard rate ratios, as a measure of relative risk, were estimated, with 95% confidence intervals (CIs) for time periods and risk factors. In the Cox analyses we adjusted for age, sex, diagnosis, modularity of the prosthesis, and fixation, and the influence on revision risk of each of these factors was assessed. Separate Cox analyses were performed on a homogenous subgroup of hips with cemented modular THAs with antibiotics in the cement on patients with OA, as this combination was common throughout the 3 time periods in all 4 countries.

The Cox survival analyses were performed with 1--16 years of follow-up, but the last time period had only 1--6 years of follow-up. To ensure that there was similar follow-up for operations in all 3 time periods, we performed additional analyses with follow-up restricted to 1--6 years for each time period. In addition, we performed separate time trend analyses of revision due to infection for men and women, all age groups, and groups of diagnoses separately. Also, the risk factors were studied in each country separately. Finally, we assessed the risk factors separately within each of the 3 time periods to minimize time-dependent confounding. Additional Cox analyses with the endpoints revision due to aseptic loosening and revision for any cause were performed to relate these to our findings on revision due to infection.

The analyses were performed in accordance with the guidelines for statistical analyses of arthroplasty register data ([@CIT0039]). The proportional-hazard assumptions of the Cox survival analyses were not completely fulfilled. We therefore assessed the proportionality of the main risk factors by smoothed Schoenfeld residuals ([Figure 3](#F3){ref-type="fig"}) ([@CIT0039]). This resulted in assessment of the risk factors before and after 1 year, since adjusted revision rates of the 3 time periods were not fully proportional. Potential overestimation of incidence of revision due to infection through the effect of competing risks (death and revision due to causes other than infection) was assessed by the cumulative incidence function ([@CIT0008]). The 3.9% of THAs that were revised for causes other than infection and the 21% of THA patients who died during the follow-up had a negligible effect on the Cox analyses.

Bilateral THAs are not independent observations, but were included. The extent of bilaterality was estimated to be 18% and the incidence of revision due to infection was 0.6% in both the first and second hip. Only 0.05% of the bilateral THAs were identified to have had revisions due to infection in both hips. We therefore considered bilaterality to have a negligible influence on the results ([@CIT0022], [@CIT0038], [@CIT0039]).

Values of p \< 0.05 were considered to be statistically significant. SPSS software version 18.0 and the R statistical software package were used for the analyses.

Results {#ss4}
=======

2,778 primary THAs (0.6%) were revised due to deep infection. The cumulative 5-year revision rate due to infection, adjusted for year of primary surgery, was 0.62% (0.60--0.65) for the study population and 0.99% (0.83--1.15) for the excluded THAs (4.4% of the total). The implants at use had changed during the study period. In the last 5-year period, there were more uncemented THAs and inverse hybrid THAs and nearly all of the cemented THAs were modular and inserted with cement containing antibiotics ([Table 1](#T1){ref-type="table"}). There were only minor changes in the distribution of patient-related risk factors over the study period, with the exception that fewer THAs were performed due to inflammatory disease and hip fracture later in the study period ([Table 1](#T1){ref-type="table"}).

Time trend of revision due to infection {#ss5}
---------------------------------------

The risk of revision due to infection increased in the period 2005--2009 relative to the period 1995--1999 in the total study population ([Table 2](#T2){ref-type="table"}; [Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}), and in each of the 4 countries separately (Denmark: RR = 1.3 (CI 1.0--1.6); Norway: RR = 1.7 (1.2--2.3); Sweden: RR = 1.5 (1.2--1.9); and Finland: RR = 1.2 (1.0--1.5)). For the period 2000--2004, the risk of revision due to infection only increased in Norway (RR = 1.3 (1.1--1.6)). The overall cumulative 5-year revision rate due to infection also increased, despite the fact that the revision rate for the period 2005--2009 might be an underestimate due to incomplete 5-year follow-up ([Table 3](#T3){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}). The subgroup of cemented modular THAs with antibiotic-loaded bone cement in OA patients showed similar results ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}; [Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).

###### 

Relative risk of revision due to infection of primary THAs in the NARA with 1-16 years of follow-up. Adjusted for age, sex, diagnosis, prosthesis, and cement

  -----------------------------------------------------------------------------------------------------------------------------------------------
                                                        Period       Number\    Number of\         Adjusted risk ratio\   95%\          p-value
                                                                     of THAs\   THAs revised\      for revision\          confidence\   
                                                                     included   due to infection   due to infection       interval      
  ----------------------------------------------------- ------------ ---------- ------------------ ---------------------- ------------- ---------
  All THAs                                              1995--1999   113,280    778                1                                    

   2000--2004                                           147,823      937        1.1                1.0--1.2               0.03          

   2005--2009                                           171,065      1,063      1.6                1.4--1.7               \<0.001       

  Uncemenxted THAs                                      1995--1999   15,177     87                 1                                    

   2000--2004                                           23,553       147        1.4                1.0--1.8               0.03          

   2005--2009                                           51,445       308        1.9                1.5--2.5               \<0.001       

  Cemented THAs                                         1995--1999   86,177     538                1                                    

   2000--2004                                           105,421      641        1.2                1.1--1.3               0.006         

   2005--2009                                           96,455       619        1.7                1.5--2.0               \<0.001       

  Hybrid THAs                                           1995--1999   11,369     149                1                                    

   2000--2004                                           15,163       125        0.8                0.6--1.0               0.02          

   2005--2009                                           10,390       63         0.8                0.6--1.1               0.2           

  Inverse hybrid THAs                                   1995--1999   556        4                  1                                    

   2000--2004                                           3,685        24         1.3                0.4--4.0               0.6           

   2005--2009                                           12,775       73         1.6                0.5--4.6               0.4           

  Cemented modular\                                     1995--1999   37,848     208                1                                    
  THAs with antibiotics in cement\                                                                                                      
  inserted due to OA **[^a^](#T2-N1){ref-type="fn"}**                                                                                   

  2000--2004                                            69,052       374        1.1                0.9--1.3               0.2           

  2005--2009                                            75,929       467        1.7                1.4--2.0               \<0.001       
  -----------------------------------------------------------------------------------------------------------------------------------------------

^a^ Adjusted for age and sex.

![Adjusted cumulative revision rates for THAs revised due to infection in 3 time periods of primary surgery, for all THAs (upper left panel) and 5 subgroups of THAs. Adjusted for age, sex, diagnosis, prosthesis, and cement. \*Adjusted for age and sex only.](ORT-1745-3674-083-449_g001){#F1}

![Graphical display of the relationship between year of primary surgery and relative risk of revision due to infection (with 95% CI), for all THAs (upper left panel) and 5 subgroups of THAs. The broken lines represent no difference in relative risk from the beginning of the period (RR = 1). Adjusted for age, sex, diagnosis, prosthesis, and cement. \*Adjusted for age and sex.](ORT-1745-3674-083-449_g002){#F2}

###### 

Adjusted cumulative 5-year revision rates of primary THAs in the NARA. Adjusted for age, sex, diagnosis, prosthesis, and cement

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                        Period       Number\    Cumulative 5-years revision rate                                                                                             
                                                                     of THAs\                                                                                                                                
                                                                     included                                                                                                                                
  ----------------------------------------------------- ------------ ---------- ---------------------------------- -------------- -------------- -------------- -------------- -------------- -------------- --------------
  All THAs                                              1995--1999   113,280    0.54                               (0.49--0.58)   0.46           (0.42--0.50)   1.41           (1.34--1.49)   3,34           (3.22--3.45)

   2000--2004                                           147,823      0.57       (0.53--0.61)                       0.54           (0.50--0.58)   0.81           (0.77--0.86)   3.01           (2.92--3.10)   

   2005--2009 **[^b^](#T3-N2){ref-type="fn"}**          171,065      0.73       (0.68--0.77)                       0.71           (0.66--0.76)   1.00           (0.93--1.07)   3.30           (3.19--3.41)   

  Uncemented THAs                                       1995--1999   15,177     0.36                               (0.26--0.45)   0.34           (0.25--0.44)   1.32           (1.13--1.50)   4.39           (4.05--4.72)

   2000--2004                                           23,553       0.55       (0.45--0.65)                       0.52           (0.43--0.61)   0.85           (0.73--0.97)   4.28           (4.02--4.54)   

   2005--2009 **[^b^](#T3-N2){ref-type="fn"}**          51,445       0.70       (0.61--0.78)                       0.65           (0.57--0.74)   1.21           (1.08--1.34)   4.24           (4.02--4.45)   

  Cemented THAs                                         1995--1999   86,177     0.51                               (0.47--0.56)   0.43           (0.38--0.48)   1.34           (1.25--1.43)   2.82           (2.70--2.94)

   2000--2004                                           105,421      0.56       (0.51--0.60)                       0.52           (0.48--0.57)   0.74           (0.68--0.79)   2.53           (2.43--2.63)   

   2005--2009 **[^b^](#T3-N2){ref-type="fn"}**          96,455       0.74       (0.68--0.81)                       0.74           (0.67--0.80)   0.85           (0.77--0.94)   2.93           (2.80--3.07)   

  Hybrid THAs                                           1995--1999   11,369     0.94                               (0.76--1.12)   0.88           (0.70--1.06)   1.82           (1.55--2.09)   4.92           (4.50--5.34)

   2000--2004                                           15,163       0.72       (0.58--0.85)                       0.67           (0.53--0.80    0.98           (0.81--1.14)   3.79           (3.48--4.10)   

   2005--2009 **[^b^](#T3-N2){ref-type="fn"}**          10,390       0.72       (0.54--0.90)                       0.67           (0.50--0.85)   1.00           (0.75--1.25)   3.86           (3.41--4.31)   

  Inverse hybrid THAs                                   1995--1999   556        0.77                               (0.02--1.51)   0.36           (0--1.38)      2.36           (0.97--3.75    5.59           (3.65--7.54)

   2000--2004                                           3,685        0.53       (0.29--0.77)                       0.34           (0--1.27)      1.64           (1.19--2.09)   3.98           (3.31--4.64)   

   2005--2009 **[^b^](#T3-N2){ref-type="fn"}**          12,775       0.66       (0.50--0.83)                       0.43           (0--1.58)      1.37           (1.02--1.72)   3.67           (3.20--4.14)   

  Modular THAs with\                                    1995--1999   37,848     0.43                               (0.36--0.49)   0.40           (0.33--0.46)   1.18           (0.67--1.69)   2.60           (2.44--2.77)
  antibiotics in cement\                                                                                                                                                                                     
  in patients with OA**[^a^](#T3-N1){ref-type="fn"}**                                                                                                                                                        

  2000--2004                                            69,052       0.49       (0.44--0.55)                       0.47           (0.41--0.52)   0.69           (0.39--0.99)   2.21           (2.10--2.32)   

  2005--2009 **[^b^](#T3-N2){ref-type="fn"}**           75,929       0.71       (0.64--0.77)                       0.67           (0.60--0.73)   0.78           (0.44--1.12)   2.60           (2.46--2.75)   
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ Adjusted for age and sex.

^b^ Cumulative 5-year revision rates probably were underestimates due to incomplete 5-year follow-up.

The entire increase in risk of revision due to infection occurred within 1 year of primary surgery, and most notably within the first 3 months after surgery ([Table 4](#T4){ref-type="table"}; [Figures 1](#F1){ref-type="fig"} and [3](#F3){ref-type="fig"}). The increased risk of revision due to infection was found for cemented and uncemented THAs, but not for hybrid THAs and inverse hybrid THAs ([Table 2](#T2){ref-type="table"}; [Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). The increase in risk of revision due to infection was more gradual through the time periods for uncemented THAs than for cemented THAs, where the main increase in relative risk of revision and cumulative 5-year revision rate was in the last time period ([Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}; [Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).

###### 

Adjusted relative risks of revision due to infection for 4 different time intervals after primary surgery, for the 3 time periods. Adjusted for age, sex, diagnosis, prosthesis, and cement

  -------------------------------------------------------------------------------------------
  Time after\       Number\    Number of\         Adjusted risk ratio\   95% CI     p-value
  primary surgery   of THAs\   THAs revised\      for revision\                     
                    included   due to infection   due to infection                  
  ----------------- ---------- ------------------ ---------------------- ---------- ---------
  0--3 months                                                                       

   1995--1999       113,280    74                 1                                 

   2000--2004       147,823    175                1.9                    1.4--2.4   \<0.001

   2005--2009       171,065    535                4.8                    3.7--6.2   \<0.001

  3--12 months                                                                      

   1995--1999       111,607    142                1                                 

   2000--2004       145,625    206                1.3                    1.0--1.6   0.05

   2005--2009       168,019    216                1.2                    1.0--1.5   0.09

  1--2 years                                                                        

   1995--1999       109,178    164                1                                 

   2000--2004       142,589    195                1.1                    0.9--1.3   0.6

   2005--2009       164,758    175                1.0                    0.8--1.3   0.9

  \> 2 years                                                                        

   1995--1999       105,338    398                1                                 

   2000--2004       138,270    361                0.9                    0.8--1.1   0.5

   2005--2009       126,131    137                0.9                    0.7--1.1   0.2
  -------------------------------------------------------------------------------------------

![A graphical display of the relationship between relative risk of revision due to infection and time after primary THAs for the period 2000--2004 (left panel) and 2005--2009 (right panel) compared to 1995--1999 (blue lines). Smoothed Schoenfeld residuals adjusted for age, sex, diagnosis, prosthesis and cement (solid lines) with 95% confidence intervals (broken lines).](ORT-1745-3674-083-449_g003){#F3}

The risk of revision due to infection increased similarly for men and women, in all age groups and for the different diagnoses, as well as for the excluded cases.

Time trend of revision due to aseptic loosening and revision for any cause {#ss6}
--------------------------------------------------------------------------

The adjusted cumulative 5-year revision rate due to aseptic loosening was lower in 2000--2004 and 2005--2009 than in 1995--1999, but the last time period did not have complete 5-year follow-up and would have been an underestimate ([Table 3](#T3){ref-type="table"}). For uncemented THAs, the cumulative 5-year revision rate due to aseptic loosening did not improve during the study period ([Table 3](#T3){ref-type="table"}). For revisions due to any cause, there was no improvement in cumulative 5-year revision rate during the study period, except for hybrid THA, despite the incomplete 5-year follow-up in 2005--2009 ([Table 3](#T3){ref-type="table"}). Compared to other methods of fixation, cemented THA had the lowest cumulative 5-year revision rate for any cause in 2005--2009 ([Table 3](#T3){ref-type="table"}).

Risk factors for revision due to infection {#ss7}
------------------------------------------

Male sex and THA performed due to inflammatory disease, hip fracture, or femoral head necrosis were the patient-related risk factors associated with increased risk of revision due to infection ([Table 5](#T5){ref-type="table"}). Implant-related risk factors that increased the relative risk of revision due to infection were hybrid fixation and plain bone cement ([Table 5](#T5){ref-type="table"}). The findings were similar when we assessed the risk factors within each time period separately and before and after 1 year after primary surgery. The exception was patients of advanced age at primary THA, who had a higher risk of revision due to infection within the first year after surgery, whereas they had a lower risk of revision due to infection more than 1 year postoperatively.

###### 

Adjusted relative risks and adjusted cumulative 5-year revision rates for risk factors for revision due to infection. All risk factors were adjusted mutually for the other risk factors in addition to the year of primary surgery. Follow-up in the risk analyses was 1-16 years

  -------------------------------------------------------------------------------------------------------------------------------
                           Number\    Number of\         Adjusted risk ratio\   95%\          p-value   Adjusted cumulative\
                           of THAs\   THAs revised\      for revision\          confidence\             5-years revision rate,\
                           included   due to infection   due to infection       interval                infection
  ------------------------ ---------- ------------------ ---------------------- ------------- --------- -------------------------
  Age (years)                                                                                           

   \<40                    5,590      39                 1                                              0.47

   40--51                  74,107     515                1.1                    0.8--1.5      0.6       0.59

   60--69                  129,134    854                1.1                    0.8--1.5      0.7       0.58

   70--79                  157,292    1,021              1.1                    0.8--1.5      0.6       0.62

   80--89                  63,034     337                0.9                    0.7--1.3      0.8       0.52

   ≥90                     3,011      12                 0.7                    0.4--1.4      0.3       0.32

  Sex                                                                                                   

   Female                  266,42     1,312              1                                              0.46

   Male                    165,748    1,466              1.9                    1.8--2.1      \<0.001   0.87

  Diagnosis                                                                                             

   Osteoarthritis          345,925    2,090              1                                              0.54

   Hip fracture            33,572     327                2.1                    1.9--2.4      \<0.001   1.12

   Inflammatory disease    15,771     118                1.4                    1.1--1.7      0.001     0.72

   Childhood hip disease   14,983     80                 0.9                    0.7--1.2      0.6       0.51

   Femoral head necrosis   9,671      92                 1.7                    1.4--2.1      \<0.001   0.87

   Other diagnoses         12,246     71                 1.3                    1.0--1.6      0.06      0.65

  Prosthesis                                                                                            

   Modular                 388,371    2,475              1                                              0.58

   Monoblock               43,797     303                1.1                    1.0--1.3      0.09      0.69

  Fixation                                                                                              

   Uncemented              90,177     542                1                                              0.54

   Cemented                288,053    1,798              1.1                    1.0--1.2      0.09      0.58

   Hybrid                  36,922     337                1.6                    1.4--1.8      \<0.001   0.79

   Inverse hybrid          17,016     101                1.0                    0.8--1.3      0.7       0.53

  Cement                                                                                                

   With antibiotics        316,072    1,997              1                                              0.58

   Without antibiotics     25,921     239                1.5                    1.3--1.8      \<0.001   0.96
  -------------------------------------------------------------------------------------------------------------------------------

Discussion {#ss8}
==========

Our main finding was the higher risk of revision due to infection after primary uncemented and cemented THAs in the 4 Nordic countries for the period 2005--2009 than for the period 1995--1999. This confirms earlier reports from Norway and Denmark ([@CIT0001], [@CIT0035]). The cumulative 5-year revision rate due to infection was also higher in 2005--2009 than in the previous 2 time periods. This was the case even though the revision rates for 2005--2009 probably were underestimates due to the incomplete 5-year follow-up, and they might therefore have been expected to be even higher.

None of the risk factors that we assessed could explain the increased risk of revision due to infection. The incidence of unfavorable risk factors (male sex, hybrid fixation, cement without antibiotics, and THA performed due to inflammatory disease, hip fracture, or femoral head necrosis) did not increase during the study period. In addition, these confounders were adjusted for in the analyses. An increased incidence of prosthetic joint infection would therefore have to be caused by factors that are not registered in the NARA dataset. These may include changes in patient-related factors (i.e. more comorbidity), changes in microbiology (i.e. increased bacterial virulence or more resistant strains), or changes in surgery-related factors (i.e. duration of surgery or changed surgical technique).

The common NARA dataset contains only limited information on comorbidity, which is a well-documented risk factor for infection after THA ([@CIT0040], [@CIT0036], [@CIT0035], [@CIT0002]). If THA was performed on more patients with poor health in the later parts of the study period, an increased incidence of prosthetic joint infections could result. In Norway, the comorbidity at THA increased during 2005--2009 ([@CIT0044]). The incidence of specific comorbidities associated with increased risk of infection after THA, like obesity and diabetes, is increasing in several countries ([@CIT0034], [@CIT0003], [@CIT0012], [@CIT0030], [@CIT0004], [@CIT0019]). Given that the THA patients reported to the NARA are representative of the general population, an increased incidence of prosthetic joint infections requiring revision could result.

Surgery-related risk factors such as duration of surgery, and timing and type of systemic antibiotic prophylaxis are also not included in the NARA dataset. However, both short and long duration of surgery have been shown to be risk factors for infection ([@CIT0040], [@CIT0036], [@CIT0001], [@CIT0035], [@CIT0002]). Less compliance to guidelines for optimal systemic prophylaxis could also have contributed to an increased incidence of prosthetic joint infections, as could an increase in bacterial resistance to antibiotic prophylaxis ([@CIT0020], [@CIT0042], [@CIT0043], [@CIT0025]). Finally, changes in operation room ventilation or changed adherence to guidelines of prophylactic routines may also have influenced the trend of revision due to infection ([@CIT0031], [@CIT0001]).

Other confounders not reported to the NARA may have contributed to an increase in reporting of revision due to infection to the registers without reflecting a corresponding increase in true incidence of prosthetic joint infection. Such confounders could be improved reporting of revisions due to infection, changes in revision policy and in the threshold of revision (i.e. new surgical methods), or changes in diagnostics (i.e. improved microbiological detection methods and changed definitions) ([@CIT0001], [@CIT0035]).

Since 2000, in Norway there has been an increase in the reporting of minor revision procedures, such as soft tissue debridement procedures with exchange of removable parts of modular implants and retention of the femoral stem and acetabular cup ([@CIT0005]). Such procedures were reported to the registers as revision procedures because prosthesis parts were exchanged. These minor revisions may have different indications or a lower threshold to be performed than full exchange revisions. Such minor revisions may also be performed and reported earlier postoperatively than full exchange revisions. This may be the reason for the increased risk of revision due to infection in the first year after primary surgery, as found for the latter 2 time periods. In addition, similar operations performed on monoblock prostheses would not be reported because heads and liners were not exchanged. We adjusted for this potential under-reporting of infected monoblock prostheses in the analyses. In addition, the minor partial revisions were most likely used as alternatives to complete exchange procedures rather than alternatives to no revision at all. This is supported by the finding of a higher risk of revision due to infection in 2005--2009 than in 1995--1999 both for the uncemented THAs, which were all modular, and for the more homogenous subgroup of modular THAs inserted with cement containing antibiotics in patients with OA. In addition, in Norway the incidence of major revision due to infection increased during 1995--2009 as well ([@CIT0005]). Thus, we do not think that increased use of modular implants and the changes in revision policy could explain the increased risk of revision due to infection.

There have been improvements in the diagnostics of prosthetic joint infections. Some bacteria such as coagulase-negative staphylococci have been increasingly acknowledged for their pathogenicity (von [@CIT0047]). In addition, improvements in bacterial sampling and identification may also have increased the number of infections being identified preoperatively ([@CIT0045], [@CIT0028]). The clinical presentation of an aseptic loosening and a low-grade periprosthetic infection may also be similar ([@CIT0046], [@CIT0018], [@CIT0029]). If knowledge and awareness changed during the study period, there may have been a corresponding change in reporting of infection as the cause of the revision. Unexpectedly positive peroperative bacterial samples would be identified postoperatively and would not be reported to the registers. Some prosthetic joint infections may therefore have been erroneously registered as aseptic loosening in the NARA, but possibly to a lesser extent in the later stages of the study period due to improvements in diagnostics.

Our finding of increased risk of revision due to infection, which is the definition of infection used by the NARA, most probably reflects a true increase in incidence of prosthetic joint infections. To our knowledge, there have been no publications on time trends of the incidence of prosthetic joint infections after primary THA. [@CIT0021] reported a 2-fold increase in overall incidence of deep infection after THA from 0.66% in 1990 to 1.23% in 2004. This study on "total infection burden" was based on aggregated data, without any linkage between primary THA and revision after discharge and with both primary and revision arthroplasty included in the analyses. For primary THAs only, the authors found a reduced incidence of infection, most probably due to shorter length of hospital stay.

Another manifestation of infection after THA is surgical site infection, which a subject of interest in large infection surveillance programs. The definition of surgical site infection is wider than those of prosthetic joint infection and revision due to infection: the risk pattern is different and the follow-up is more limited than in arthroplasty registers ([@CIT0014], [@CIT0002]). It may be that the treatment strategy for early postoperative soft tissue infections has become more aggressive in recent years, resulting in an increased revision rate. However, only one fifth of the surgical site infections reported to the Norwegian Surveillance System for Healthcare Associated Infections after primary THAs were reported to the Norwegian Arthroplasty Register for revisions due to infection in the period 2005--2009 ([@CIT0002]). Both revision due to infection and surgical site infection will be surrogate endpoints of true prosthetic joint infections ([@CIT0032]).

The Dutch National Nosocomial Surveillance Network (PREZIES) reported a decrease in surgical site infections after primary THA between 1996 and 2006 ([@CIT0027]), as did the British mandatory surveillance of SSI between 2004 and 2010 ([@CIT0013]). Capture of surgical site infections is highly dependent on length of stay after primary THA or type and length of post-discharge surveillance ([@CIT0017]). For instance, low-grade prosthetic joint infections, presenting as pain and loosening of the implant at a later stage, will generally be missed in surveillance programs for surgical site infection. The reported decrease in the incidence of surgical site infections may therefore be due to shorter length of stay and limited post-discharge surveillance, and not to a reduction in the incidence of prosthetic joint infections in need of revision ([@CIT0027], [@CIT0013]).

A previous study from Norway found that uncemented THAs had a higher risk of revision due to infection than cemented THAs ([@CIT0001]). A study from Denmark, in contrast, found that cemented THAs had higher risk of revision due to infection than uncemented THAs ([@CIT0035]). In the present study, the overall risk of revision due to infection was similar for cemented, inverse hybrid, and uncemented THAs.

We found an incidence of revision due to infection of 0.6%; it is therefore a relatively rare complication after THA. Large populations are required for the study of time trends and risk factors for such rare events. The large NARA dataset offers an opportunity for in-depth studies of revision due to infection even in subgroups with sufficient power. The data are prospective and have a high degree of completeness ([@CIT0041], [@CIT0033], [@CIT0006]). The completeness of the NARA dataset and the small proportion of cases excluded in the present study (4.4%) also indicate that there was minimal selection bias, even if the relative risk of revision due to infection was higher in the excluded group. The time trend of revision due to infection was similar for the included cases and the excluded cases. The number of variables in the NARA dataset is limited, however, and even though we adjusted for several well-known confounders in our analyses, unmeasured confounding would still be a problem.

Considering the size and quality of the NARA dataset, and the adjustment for several clinically important risk factors, we believe that there has been a true increase in the risk of prosthetic joint infections. The largest increase in relative risk of revision due to infection was for uncemented THAs, but the overall risk of revision due to infection was similar for cemented, uncemented, and inverse hybrid THAs. Male sex, hybrid fixation, cement without antibiotics, and THA performed due to inflammatory disease, hip fracture, or femoral head necrosis were risk factors for revision due to infection.
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